Anteris Technologies Global Corp. filed a preliminary proxy statement on October 28, 2026, noticing its 2026 Annual Meeting of Stockholders to be held on December 2, 2026, at 4:00 p.m. Central time, with 21 proposals on the agenda covering director elections, auditor ratification, and multiple equity award approvals.

Key Highlights

  • Annual Meeting Date: December 2, 2026, at 4:00 p.m. Central time, in person at the InterContinental Sydney, 16 Phillip Street, Sydney, NSW, 2000, Australia, with a virtual attendance option.
  • Record Date: Stockholders of record as of the close of business on October 29, 2026, are entitled to notice and voting rights.
  • Director Election: David St Denis and Stephen Denaro are nominated as Class II directors, each to serve until the 2029 annual meeting of stockholders.
  • CEO Equity Grants Proposed: Wayne Paterson is proposed to receive 629,921 RSUs for 2025 service and 1,200,000 Option Rights plus 800,000 PSUs for 2026.
  • Auditor Ratification: Stockholders are asked to ratify the appointment of KPMG as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
  • RSU Amendment: Proposal Sixteen seeks approval to amend the terms of RSUs previously granted under the Anteris Technologies Global Corp. Equity Incentive Plan, pursuant to ASX Listing Rule 6.23.4.
  • CDI Holder Voting Restriction: According to the filing, holders of CHESS Depositary Interests are entitled to attend the meeting but cannot vote electronically or in person during the meeting itself; they must direct CDN to vote in advance.

Anteris Technologies Puts Extensive 2026 Equity Compensation Program to Stockholder Vote

Anteris Technologies Global Corp., a Delaware corporation that also has securities listed on the Australian Securities Exchange in the form of CHESS Depositary Interests, filed a preliminary proxy statement on October 28, 2026, calling its 2026 Annual Meeting of Stockholders. The company, which is focused on the development of cardiac valve replacement technology, has structured the meeting agenda to address a wide range of compensation and governance matters requiring stockholder approval under both U.S. securities rules and ASX Listing Rules.

According to the filing, the agenda includes 21 separate proposals. Beyond the routine election of directors and auditor ratification, the proposals cover equity grants to named executive officers and non-employee directors. Chief Executive Officer Wayne Paterson is proposed to receive 629,921 RSUs related to his 2025 employment, along with 1,200,000 Option Rights and 800,000 PSUs for 2026. President David St Denis is proposed to receive 314,960 RSUs for 2025 and 485,000 PSUs plus 414,000 Option Rights for 2026. Non-employee directors John Seaberg, Gregory Moss, David Roberts, Stephen Denaro, and Susan Knight are each proposed to receive Option Rights valued at between $220,000 and $250,000 under the Non-Employee Director Compensation Policy, with certain directors also proposed to receive additional appointment-related Option Rights of $220,000 in grant date value.

The filing also discloses a proposal, Proposal Nineteen, to issue up to $540,000 in aggregate grant date value of shares of Common Stock to John Seaberg in lieu of all or a portion of his cash retainer fees. A corresponding proposal, Proposal Twenty, would permit the issuance of up to $330,000 in aggregate grant date value of CDIs to Stephen Denaro in lieu of cash retainer fees. All equity proposals require ASX Listing Rule 10.14 approval in addition to general stockholder approval. The Common Stock has a par value of $0.0001 per share, according to the filing.

What Was Disclosed

Anteris Technologies Global Corp. filed a preliminary Schedule 14A proxy statement, dated October 28, 2026, noticing a December 2, 2026, annual meeting with 21 proposals covering director elections, KPMG ratification, numerous equity grants to executives and directors, an RSU plan amendment, and stock-in-lieu-of-cash retainer arrangements.